Chao-Ping Wu

Chao-Ping Wu practices at Fairview Hospital in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Chao-Ping Wu's NPI, 1275933251, was assigned on August 27, 2014. Chao-Ping Wu holds New York license 290833.

Chao-Ping Wu's primary practice is Fairview Hospital, at 18101 Lorain Avenue, Cleveland, OH 44111 in Cuyahoga County. The practice phone is (216) 476-7000.

Chao-Ping Wu's primary practice is Fairview Hospital in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Chao-Ping Wu is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Chao-Ping Wu to 2 more hospitals and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Chao-Ping Wu practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Chao-Ping Wu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Chao-Ping Wu is licensed in New York.

CMS data shows 278 Medicare services from Chao-Ping Wu across 6 procedure codes in 2024, for 199 Medicare patients. Medicare paid $34,711 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 199 Medicare patients who saw Chao-Ping Wu in 2024. The largest group is 75 to 84, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 3.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Chao-Ping Wu's median patient age at 65, with 46% women.

In 2020, Chao-Ping Wu wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $53 in total drug cost. In 2017, CMS named 26 claims across 2 drugs.

Chao-Ping Wu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Chao-Ping Wu from 3 drug and device companies from 2018 to 2021. Food and beverage make up the largest share, 100% of the total. Insmed, Inc. paid the most, $237.